Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 2/20 | 0.32 |
| ▸ | HTR2A | P28223 | 2/20 | 0.32 |
| ▸ | HRH1 | P35367 | 2/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | FDPS | P14324 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.32 |
| ▸ | EYA2 | O00167 | 1/20 | 0.32 |
| ▸ | APP | P05067 | 1/20 | 0.32 |
| ▸ | ACE | P12821 | 1/20 | 0.32 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.31 |
| ▸ | DRD3 | P35462 | 2/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL957226 | 0.91 | FFAR3 (0.35) | ADRA2AHTR2AHRH1TDP1EYA2 | |
| SCHEMBL215964 | 0.91 | FFAR3 (0.35) | ADRA2AHTR2AHRH1TDP1EYA2 | |
| SCHEMBL155767 | 0.86 | FDPS (0.37) | ADRA2AHTR2AHRH1PGRADRA2B | |
| SCHEMBL19886164 | 0.86 | FDPS (0.37) | ADRA2AHTR2AHRH1PGRADRA2B | |
| SCHEMBL3785080 | 0.86 | FDPS (0.37) | ADRA2AHTR2AHRH1PGRADRA2B | |
| Glycine SCHEMBL8537150 | 0.83 | GLRA1 (0.30) | — | |
| Acetamide SCHEMBL5961960 | 0.82 | LMNA (0.31) | LMNAALOX15BLMPMP22 | |
| SCHEMBL5177311 | 0.82 | TDP1 (0.33) | ADRA2ATDP1EYA2APPACE | |
| SCHEMBL29016771 | 0.82 | HTR2A (0.31) | ADRA2AHTR2AHRH1PGRADRA2B | |
| SCHEMBL8825871 | 0.80 | TDP1 (0.52) | ADRA2ATDP1EYA2APPACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2432846-B1 | NOVEL FORMULATIONS OF WATER-SOLUBLE POLYMERS AND STABILIZING ADDITIVES FOR INJECTING A SINGLE COMPOUND USEABLE IN INJECTION FLUIDS FOR CHEMICAL ENHANCED OIL RECOVERY | SPCM SA (FR) | 2019-05-01 | — | — | EP | claimed |
| EP-1737899-B1 | DENDRITIC POLYMERS WITH ENHANCED AMPLIFICATION AND INTERIOR FUNCTIONALITY | DENDRITIC NANOTECHNOLOGIES INC (US) | 2015-07-08 | — | — | EP | claimed |
| EP-2385078-A1 | Dendritic polymers with enhanced amplification and interior functionality | Dendritic Nanotechnologies Inc. (US) | 2011-11-09 | — | — | EP | claimed |
| US-20110254461-A1 | Power adaptors | HOLDIP LIMITED (GB) | 2011-10-20 | — | — | US | claimed |
| US-7985424-B2 | Dendritic polymers with enhanced amplification and interior functionality | DENDRITIC NANOTECHNOLOGIES INC. (US) | 2011-07-26 | — | — | US | claimed |
| US-7981444-B2 | Dendritic polymers with enhanced amplification and interior functionality | DENDRITIC NANOTECHNOLOGIES, INC. (US) | 2011-07-19 | — | — | US | claimed |
| EP-2325236-A1 | Dendritic polymers with enhanced amplification and interior functionality | Dendritic Nanotechnologies Inc. (US) | 2011-05-25 | — | — | EP | claimed |
| JP-2008545621-A | — | — | 2008-12-18 | — | — | JP | claimed |
| EP-1737899-A4 | DENDRITIC POLYMERS WITH ENHANCED AMPLIFICATION AND INTERIOR FUNCTIONALITY | DENDRITIC NANOTECHNOLOGIES INC (US) | 2008-03-05 | — | — | EP | claimed |
| EP-1877103-A2 | DENDRITIC POLYMERS WITH ENHANCED AMPLIFICATION AND INTERIOR FUNCTIONALITY | Dendritic Nanotechnologies, Inc. (US) | 2008-01-16 | — | — | EP | claimed |
| US-20070298006-A1 | Dendritic Polymers With Enhanced Amplification and Interior Functionality | DENDRITIC NANOTECHNOLOGIES, INC. (US) | 2007-12-27 | — | — | US | claimed |
| US-20070244296-A1 | Dendritic Polymers with Enhanced Amplification and Interior Functionality | DENDRITIC NANOTECHNOLOGIES, INC. (US) | 2007-10-18 | — | — | US | claimed |
| EP-1737899-A2 | DENDRITIC POLYMERS WITH ENHANCED AMPLIFICATION AND INTERIOR FUNCTIONALITY | Dendritic Nanotechnologies, Inc. (US) | 2007-01-03 | — | — | EP | claimed |
| WO-2006065266-A9 | DENDRITIC POLYMERS WITH ENHANCED AMPLIFICATION AND INTERIOR FUNCTIONALITY | DENDRITIC NANOTECHNOLOGIES INC (US) | 2006-12-21 | — | — | WO | claimed |
| WO-2006115547-A2 | DENDRITIC POLYMERS WITH ENHANCED AMPLIFICATION AND INTERIOR FUNCTIONALITY | DENDRITIC NANOTECHNOLOGIES, INC. (US) | 2006-11-02 | — | — | WO | claimed |
| WO-2006065266-A2 | DENDRITIC POLYMERS WITH ENHANCED AMPLIFICATION AND INTERIOR FUNCTIONALITY | DENDRITIC NANOTECHNOLOGIES, INC. (US) | 2006-06-22 | — | — | WO | claimed |
| US-4581221-A | TECHNETIUM LABELLED CARRIER REACTED WITH AN ULCER SPECIFIC OLIGOSACCHARIDE SULFATE | MEDI NUCLEAR CORPORATION, INC. (US) | 1986-04-08 | — | — | US | claimed |
| US-4117225-A | ANTICONVULSANTS | G.D. SEARLE & CO. (US) | 1978-09-26 | — | — | US | claimed |
| CN-118382612-A | Method for producing blocked isocyanate compound and method for producing isocyanate compound | 旭化成株式会社 | 2024-07-23 | — | — | CN | disclosed |
| US-4117225-A | ANTICONVULSANTS | G.D. SEARLE & CO. (US) | 1978-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070298006-A1 | Dendritic Polymers With Enhanced Amplification and Interior Functionality | MYD88, TLR3, TMEM97 | ADRA2A 677/4885HTR2A 2325/4885HRH1 205/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.